AU8300282A - Bacillus cloning vectors and method of expressing foreign dna - Google Patents

Bacillus cloning vectors and method of expressing foreign dna

Info

Publication number
AU8300282A
AU8300282A AU83002/82A AU8300282A AU8300282A AU 8300282 A AU8300282 A AU 8300282A AU 83002/82 A AU83002/82 A AU 83002/82A AU 8300282 A AU8300282 A AU 8300282A AU 8300282 A AU8300282 A AU 8300282A
Authority
AU
Australia
Prior art keywords
foreign dna
cloning vectors
expressing foreign
bacillus cloning
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU83002/82A
Other languages
English (en)
Inventor
Allistair Harold Arthur Bingham
Kimber Graham Hardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen NV
Original Assignee
Biogen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen NV filed Critical Biogen NV
Publication of AU8300282A publication Critical patent/AU8300282A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AU83002/82A 1981-04-29 1982-04-27 Bacillus cloning vectors and method of expressing foreign dna Abandoned AU8300282A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8113253 1981-04-29
GB8113253 1981-04-29

Publications (1)

Publication Number Publication Date
AU8300282A true AU8300282A (en) 1982-11-04

Family

ID=10521486

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83002/82A Abandoned AU8300282A (en) 1981-04-29 1982-04-27 Bacillus cloning vectors and method of expressing foreign dna

Country Status (12)

Country Link
EP (1) EP0063953A3 (OSRAM)
JP (1) JPS57181099A (OSRAM)
AU (1) AU8300282A (OSRAM)
BR (1) BR8202422A (OSRAM)
DD (1) DD203331A5 (OSRAM)
DK (1) DK188582A (OSRAM)
ES (1) ES8306797A1 (OSRAM)
FI (1) FI821466L (OSRAM)
GR (1) GR75411B (OSRAM)
NO (1) NO821391L (OSRAM)
PT (1) PT74811B (OSRAM)
ZA (1) ZA822855B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568597B2 (en) * 1982-08-17 1988-01-07 Biogen N.V. Dna sequences, recombinant dna molecules and process for producing bovine growth hormone-like polypeptides

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
IT1156317B (it) * 1982-09-08 1987-02-04 Anic Spa Vettori plasmidici ad espressione in bacillus subtilis e procedimento per la loro preparazione
US4783405A (en) * 1983-01-18 1988-11-08 Eli Lilly And Company Recombinant DNA expression vectors useful in bacillus and other host cells
US4559300A (en) * 1983-01-18 1985-12-17 Eli Lilly And Company Method for using an homologous bacillus promoter and associated natural or modified ribosome binding site-containing DNA sequence in streptomyces
US4595660A (en) * 1983-03-02 1986-06-17 University Of Delaware Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis, mutants and substantially stably transformed mutants of Bacillus subtilis, and methods for utilizing the transformed mutants
US4649119A (en) * 1983-04-28 1987-03-10 Massachusetts Institute Of Technology Cloning systems for corynebacterium
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
US4912046A (en) * 1983-06-27 1990-03-27 Genentech, Inc. Portable inducible control system
JPS6041697A (ja) * 1983-08-15 1985-03-05 Asahi Chem Ind Co Ltd 活性蛋白質誘導体の新規合成法
JPS60137291A (ja) * 1983-12-26 1985-07-20 Takeda Chem Ind Ltd 発現ベクター
JPH0630583B2 (ja) * 1984-01-27 1994-04-27 武田薬品工業株式会社 Ｄνａおよびその用途
JPS60188093A (ja) * 1984-03-09 1985-09-25 Teruhiko Beppu 枯草菌に於ける形質発現プラスミド
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US5171673A (en) * 1988-07-18 1992-12-15 Biotechnica International, Inc. Expression of heterologous dna using the bacillus coagulans amylase gene
IE914102A1 (en) 1990-11-26 1992-06-03 Genetics Inst Expression of pace in host cells and methods of use thereof
CA2308606A1 (en) 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
SG123535A1 (en) 1998-01-14 2006-07-26 Chiron Srl Neisseria meningitidis antigens
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
EP2261340B1 (en) 1998-05-01 2017-03-08 GlaxoSmithKline Biologicals SA Neisseria meningitidis antigens and compositions
ES2522667T3 (es) 1999-04-30 2014-11-17 Novartis Vaccines And Diagnostics S.R.L. Antígenos Neisseriales conservados
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
ES2541830T3 (es) 1999-10-29 2015-07-27 Novartis Vaccines And Diagnositics S.R.L. Péptidos antigénicos de Neisseria
ES2507100T3 (es) 2000-01-17 2014-10-14 Novartis Vaccines And Diagnostics S.R.L. Vacuna OMV suplementada contra meningococo
MX357775B (es) 2000-10-27 2018-07-20 J Craig Venter Inst Inc Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
ATE406912T1 (de) 2001-12-12 2008-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia tracheomatis
CA2485703A1 (en) 2002-05-24 2003-12-04 Fred W. Wagner Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
EP1513945A4 (en) 2002-05-24 2008-12-24 Restoragen Inc PROCESS FOR UNIVERSAL ENZYMATIC PRODUCTION OF BIOACTIVE PEPTIDES
EP1562982B1 (en) 2002-11-15 2010-05-05 Novartis Vaccines and Diagnostics S.r.l. Unexpected surface proteins in neisseria meningitidis
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
CA2546319A1 (en) 2003-11-21 2005-07-28 Nps Allelix Corp. Production of glucagon like peptide 2 and analogs
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
PL2054431T3 (pl) 2006-06-09 2012-07-31 Novartis Ag Konformery adhezyn bakteryjnych
BRPI0907843A2 (pt) 2008-02-21 2015-08-04 Novartis Ag Polipeptídeos de fhbp menigocócicos
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
ES2562259T3 (es) 2009-08-27 2016-03-03 Glaxosmithkline Biologicals Sa Polipéptidos híbridos que incluyen secuencias fHBP meningocócicas
AU2010310985B2 (en) 2009-10-27 2014-11-06 Glaxosmithkline Biologicals S.A. Modified meningococcal fHBP polypeptides
FR2954349A1 (fr) 2009-12-22 2011-06-24 Agronomique Inst Nat Rech Sulfatase modifiant selectivement les glycosaminoglycanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2048894A (en) * 1979-05-11 1980-12-17 Gist Brocades Nv Plasmid
AU545912B2 (en) * 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
EP0057496A3 (en) * 1981-01-06 1983-03-16 The Public Health Laboratory Service Board Chimeric plasmids
CA1204681A (en) * 1981-04-20 1986-05-20 Cetus Corporation Method and vector organism for controlled accumulation of cloned heterologous gene products in bacillus subtilis ii

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568597B2 (en) * 1982-08-17 1988-01-07 Biogen N.V. Dna sequences, recombinant dna molecules and process for producing bovine growth hormone-like polypeptides

Also Published As

Publication number Publication date
PT74811A (en) 1982-05-01
PT74811B (en) 1983-10-26
GR75411B (OSRAM) 1984-07-16
EP0063953A3 (en) 1983-10-19
NO821391L (no) 1982-11-01
JPS57181099A (en) 1982-11-08
FI821466A7 (fi) 1982-10-30
ES511741A0 (es) 1983-06-01
FI821466L (fi) 1982-10-30
DK188582A (da) 1982-10-30
BR8202422A (pt) 1983-04-12
EP0063953A2 (en) 1982-11-03
FI821466A0 (fi) 1982-04-27
DD203331A5 (de) 1983-10-19
ZA822855B (en) 1983-03-30
ES8306797A1 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
AU8300282A (en) Bacillus cloning vectors and method of expressing foreign dna
AU587988B2 (en) Modified membrane suppressor and method of use
HU9201382D0 (en) Process for the productionm of metionine-n-alpha-acetyl-transpherase enzym qnd its cloning gene
AU588220B2 (en) Improved expression vector and use thereof
AU8424082A (en) Buoyant fiber product and method of its manufacture
AU578872B2 (en) Interface apparatus and method
AU6189680A (en) Buffer composition and method for the electrophoretic separation of proteins
IL62728A (en) Assay for the determination of enzymes and means for carrying out the method
AU559926B2 (en) Steel grinding rods and methods of making same
AU546820B2 (en) Lenses and method of making
AU2983284A (en) Ascorbic acid intermediates and process enzymes
GB2078369B (en) Enzymatic assay method and apparatus
EG17786A (en) Vectors and method for gene expression
AU2323984A (en) Recombinant dna expression vectors useful in bacillus
ZA855023B (en) Intact gene and method of excising and cloning same
GB2168705B (en) Novel bacteriolytic enzyme and process for preparing the same
IL77068A0 (en) Switch or control cable arrangement and method of using the same
AU5314886A (en) Method of detaching micro-flora and compositions therefor
AU572502B2 (en) Plant structural gene expression using dna vectors and t-dna
AU6848694A (en) Cloning and expression of the gene of the malolactic enzyme of (lactococcus lactis)
DE3572194D1 (en) Method of cloning modified streptomycetes dna
AU534964B2 (en) Contact material and method of making
AU3581889A (en) Laundry apparatus and method of controlling such
GB2103220B (en) 27-desamidosecretin and production of same through recombinant dna technique
AU562962B2 (en) Molecular cloning and characterisation of the gene sequence coding for human relaxin